Skip to main content

Companies complying with Abbreviated New Drug Application (ANDA)

An ANDA is a submission to the FDA that provides data for the review and approval of a generic drug, allowing the applicant to manufacture and market a lower‑cost version of a brand‑name product.

1,880

companies

List of companies that comply with Abbreviated New Drug Application (ANDA)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Pharmaceutical Manufacturing

7.6k

$2.1B

Abbreviated New Drug Application (ANDA)

India

Pharmaceutical Manufacturing

32k

$5.6B

Abbreviated New Drug Application (ANDA)

United Kingdom

Pharmaceutical Manufacturing

11k

$2.3B

Abbreviated New Drug Application (ANDA)

India

Pharmaceutical Manufacturing

33k

Abbreviated New Drug Application (ANDA)

United States

Pharmaceutical Manufacturing

18k

Abbreviated New Drug Application (ANDA)

United States

Pharmaceutical Manufacturing

1.1k

Abbreviated New Drug Application (ANDA)

United States

Pharmaceutical Manufacturing

81

Abbreviated New Drug Application (ANDA)

Canada

Pharmaceutical Manufacturing

6.6k

Abbreviated New Drug Application (ANDA)

United States

Pharmaceutical Manufacturing

53

Abbreviated New Drug Application (ANDA)

Israel

Pharmaceutical Manufacturing

30k

$15B

Abbreviated New Drug Application (ANDA)

Showing top companies out of 1,880 that comply with Abbreviated New Drug Application (ANDA). Get the full list on TheirStack.

Frequently asked questions